top of page
All Posts


Melatonin: a promising new approach in Alzheimer’s treatment
Neurodegeneration Melatonin shows promise in Alzheimer's treatment by restoring circadian rhythms and reducing neurodegenerative symptoms, researchers have demonstrated in a groundbreaking study. A groundbreaking study conducted by researchers at Nanjing Pharmaceutical University has introduced an innovative therapeutic strategy for combating Alzheimer's disease , linking aging processes with neurodegenerative diseases. The researchers employed an AI-driven screening method
Georges HAZAN
Nov 253 min read
Â
Â
Â


An Interview with Carl Gordon, Managing Partner, OrbiMed Advisors
OrbiMed is a global healthcare investment firm that finances companies across all stages of the life sciences sector, from early-stage biotechs to large pharmaceutical enterprises. How would you describe the current investment climate for the biotech sector? Do you believe the difficult period the industry has faced in recent years is finally coming to an end? I think it’s an exciting time for the sector. It’s never easy to be a biotech investor, but over the last several mon
Georges HAZAN
Nov 235 min read
Â
Â
Â


European Family CIOs Rethink U.S. Exposure Amid Volatility
The geopolitical landscape is the key challenge that they face in their investment decision-making. The CIOs of British and mainland...
Georges HAZAN
Jul 153 min read
Â
Â
Â


Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem
Paris is known for many things, from romance to art to world-beating croissants. But perhaps one of its lesser-known attributes is that...
Georges HAZAN
Jul 16 min read
Â
Â
Â
bottom of page
